Glypican-3 expression in clear cell adenocarcinoma of the ovary (Q44268931)

1 December 2017

Glypican-3 expression in clear cell adenocarcinoma of the ovary (English)

1 reference

clear cell adenocarcinoma

1 December 2017

1 reference

1 reference

7

Yuji Taketani

1 reference

1 December 2017

4

Hiroyuki Aburatani

1 reference

1 December 2017

Daichi Maeda

1

1 reference

1 December 2017

Satoshi Ota

2

1 reference

1 December 2017

Yutaka Takazawa

3

1 reference

1 December 2017

Shunsuke Nakagawa

5

1 reference

1 December 2017

Tetsu Yano

6

1 reference

1 December 2017

Tatsuhiko Kodama

8

1 reference

1 December 2017

Masashi Fukayama

9

1 reference

1 December 2017

27 March 2009

1 reference

1 December 2017

1 reference

1 December 2017

22

1 reference

1 December 2017

6

1 reference

1 December 2017

824-832

1 reference

https://scigraph.springernature.com/pub.10.1038/modpathol.2009.40

1 December 2017

0 references

cites work

Mechanisms of chemoresistance and poor prognosis in ovarian clear cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.40

Glypican-3 regulates migration, adhesion and actin cytoskeleton organization in mammary tumor cells through Wnt signaling modulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.40

Low proliferation activity may be associated with chemoresistance in clear cell carcinoma of the ovary.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.40

Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.40

Survival among U.S. women with invasive epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.40

Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.40

Ovarian clear cell adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.40

Clear cell carcinoma of the ovary: a retrospective multicentre experience of 254 patients with complete surgical staging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.40

Glypicans: proteoglycans with a surprise

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.40

Glypican-3 modulates BMP- and FGF-mediated effects during renal branching morphogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.40

Processing by proprotein convertases is required for glypican-3 modulation of cell survival, Wnt signaling, and gastrulation movements

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.40

Glypican-3, overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.40

Gpc3 expression correlates with the phenotype of the Simpson-Golabi-Behmel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.40

Identification of glypican-3 as a novel tumor marker for melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.40

Glypican-3 is overexpressed in lung squamous cell carcinoma, but not in adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.40

Identification of soluble NH2-terminal fragment of glypican-3 as a serological marker for early-stage hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.40

Embryonic stem cell-derived dendritic cells expressing glypican-3, a recently identified oncofetal antigen, induce protective immunity against highly metastatic mouse melanoma, B16-F10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.40

Identification of HLA-A2- or HLA-A24-restricted CTL epitopes possibly useful for glypican-3-specific immunotherapy of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.40

Anti-glypican 3 antibody as a potential antitumor agent for human liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.40

Immunohistochemical differentiation of clear-cell carcinoma of the female genital tract and endodermal sinus tumor with the use of alpha-fetoprotein and Leu-M1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.40

“Mesonephroma” of ovary. Tumor of müllerian nature related to the endometrioid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.40

7 January 2021

Clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy in stage III disease

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.40

7 January 2021

Ovarian endometriosis associated with ovarian carcinoma: a clinicopathological and immunohistochemical study

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.40

7 January 2021

Glypican 3 expression in human nonneoplastic, preneoplastic, and neoplastic tissues: a tissue microarray analysis of 4,387 tissue samples

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.40

7 January 2021

Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.40

7 January 2021

The glypican 3 oncofetal protein is a promising diagnostic marker for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.40

7 January 2021

Oncofetal protein glypican-3 in testicular germ-cell tumor

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.40

7 January 2021

Glypican 3: a novel marker in testicular germ cell tumors

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.40

7 January 2021

Glypican-3 expression in primary and recurrent ovarian carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.40

7 January 2021

Oncofetal protein glypican-3 distinguishes yolk sac tumor from clear cell carcinoma of the ovary

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.40

7 January 2021

Immunohistochemical detection of hepatocyte nuclear factor 1beta in ovarian and endometrial clear-cell adenocarcinomas and nonneoplastic endometrium

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.40

7 January 2021

The use of cytokeratin 7 and EMA in differentiating ovarian yolk sac tumors from endometrioid and clear cell carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.40

7 January 2021

Ovarian hepatoid yolk sac tumours: morphological, immunohistochemical and ultrastructural features

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.40

7 January 2021

10.1038/MODPATHOL.2009.40

Identifiers

DOI

1 reference

1 December 2017

1 reference